Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Exscientia raises $26mm in Series B round

Executive Summary

AI drug discovery company Exscientia Ltd. raised $26mm in its Series B financing round from new investors Celgene and specialist health care investor GT Healthcare Capital Partners along with returning backer Evotec. The company plans to use the proceeds to scale its pipeline and advance selected programs toward the clinic. Exscientia expects its first programs driven by AI to be IND-ready within the next year.
Deal Industry
  • Digital Health
  • Pharmaceuticals
  • Services
  • Biotechnology
    • Drug Discovery Tools
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies